International Marketing Presentations Questions (M.Pharm + MBA) 3 Year

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 2

International Marketing Presentations Questions (M.

Pharm + MBA) 3rd year

Group No.

Major project Title

Minor Project Title

Questions 1. If you are planning to launch your product in a particular country, which primary & secondary sources of information would you use for research? 2. what are the cultural factors which you would take into consideration? 1. Do we offer a distinctive value proposition for each korean consumer segment or follow a broad approach to all segments?

1.

International Marketing Research

------

2.

Market entry strategy for South korea

----2. Because of the benefits and potential risks associated with biopharmaceuticals and biosimilars, how will be clinicians familiarize themselves with the relevant literature on the safety and efficacy of these agents in various patient populations? 1 What are the factors that will be taken into consideration before adding a new product into our product line ?? 2 Why few products in the product mix cannibalize the profit of other products ?? 1. If you want your pharmaceutical product to enter international markets, how would you go about it? 1. What is anti- kick back law & state its impact on pharmaceutical companies.

3.

Product mix & Profit mix

------

4.

------

Export management

5. ----Fraud in pharma

industry & big bad pharma

6. -----Ethics & compliance in Pharma Industry

2. Impact of corporate ghostwriting on pharma companies and write in brief about the interaction with health care professionals. 1) What measures should be taken to eradicate unethical and fraudulent activities in pharma industry ? 2) How can we minimize the loopholes in the value chain which leads to counterfeit activity? 1. According to you, how counterfeit medicines affect the pharmaceutical industry & economy of the nations?

7.

------

Counterfeit Medicines

8.

----Technology Transfer

2. Counterfeit medicines are harmful for patients , nation and pharmaceutical industry? And if yes then what are the measures should be taken to prevent counterfeit medicines enter in to the market? 1. How is technology transfer promising for the pharmaemerging nations? 2. Give examples of technology transfer by indian companies.

You might also like